Moneycontrol

Budget 2023Budget 2023

PARTNERS

  • Tata AIA Life Insurance
  • Hafele
  • Motilal Oswal
  • SMC Global Securities Limited
  • SBI Life
Upcoming Event : LeapToUnicorn - mentoring, networking and fundraising for startups. Register now
Budget 2023
Budget 2023
you are here: HomeNewsEconomyPolicy

India renews push for extending TRIPS waiver beyond Covid vaccines within two months of WTO deal

At the global WTO summit in June, nations had agreed on loosening the intellectual property rights regime only for vaccines and deciding on similar concessions for all other Covid-19 treatments, diagnostics or technologies six months later.

August 22, 2022 / 04:29 PM IST
Representative image. A makeshift health centre for battling the pandemic in SOuth Africa. Image : AP

Representative image. A makeshift health centre for battling the pandemic in SOuth Africa. Image : AP

Barely two months after it agreed to a WTO deal for temporary intellectual property rights (IP) waiver for Covid vaccines, India has restarted its campaign to extend it to other Covid drugs, diagnostics and medical technologies.

Multiple officials told Moneycontrol that they remain confident of securing support from more nations this time around.

The IP waiver for vaccine production was agreed in a WTO meet in June this year, which decided that the trade body will revisit the issue of extending it to other treatments within six months ending December.

"The latest text focuses disproportionately on the use of the compulsory licensing system. This would allow governments to permit the manufacture of vaccines and other medicines without infringement of IP rights during an emergency such as a pandemic," an official said.